The global market for Hepatitis A Inactivated Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Hepatitis A Inactivated Vaccine is a vaccine used to prevent infection with the hepatitis A virus. It can help protect individuals from infection with the hepatitis A virus and thus prevent related liver diseases.

North American market for Hepatitis A Inactivated Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Hepatitis A Inactivated Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Hepatitis A Inactivated Vaccine include Pfizer, Merck, Sanofi, GlaxoSmithKline, Health Pharma, Huakang Pharmaceutical, Limin Pharmaceutical, Xianghe Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hepatitis A Inactivated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Inactivated Vaccine.

The Hepatitis A Inactivated Vaccine market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis A Inactivated Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hepatitis A Inactivated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hepatitis A Inactivated Vaccine Market Report

Report Metric	Details
Report Name	Hepatitis A Inactivated Vaccine Market
Segment by Type	25U/0.5ml 50U/1.0ml
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Merck, Sanofi, GlaxoSmithKline, Health Pharma, Huakang Pharmaceutical, Limin Pharmaceutical, Xianghe Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis A Inactivated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis A Inactivated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hepatitis A Inactivated Vaccine Market report?

Ans: The main players in the Hepatitis A Inactivated Vaccine Market are Pfizer, Merck, Sanofi, GlaxoSmithKline, Health Pharma, Huakang Pharmaceutical, Limin Pharmaceutical, Xianghe Pharmaceutical

What are the Application segmentation covered in the Hepatitis A Inactivated Vaccine Market report?

Ans: The Applications covered in the Hepatitis A Inactivated Vaccine Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Hepatitis A Inactivated Vaccine Market report?

Ans: The Types covered in the Hepatitis A Inactivated Vaccine Market report are 25U/0.5ml, 50U/1.0ml

1 Hepatitis A Inactivated Vaccine Market Overview

1.1 Product Definition

1.2 Hepatitis A Inactivated Vaccine by Type

1.2.1 Global Hepatitis A Inactivated Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 25U/0.5ml

1.2.3 50U/1.0ml

1.3 Hepatitis A Inactivated Vaccine by Application

1.3.1 Global Hepatitis A Inactivated Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Hepatitis A Inactivated Vaccine Market Size Estimates and Forecasts

1.4.1 Global Hepatitis A Inactivated Vaccine Revenue 2020-2031

1.4.2 Global Hepatitis A Inactivated Vaccine Sales 2020-2031

1.4.3 Global Hepatitis A Inactivated Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Hepatitis A Inactivated Vaccine Market Competition by Manufacturers

2.1 Global Hepatitis A Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Hepatitis A Inactivated Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Hepatitis A Inactivated Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Hepatitis A Inactivated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Date of Enter into This Industry

2.8 Global Hepatitis A Inactivated Vaccine Market Competitive Situation and Trends

2.8.1 Global Hepatitis A Inactivated Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Hepatitis A Inactivated Vaccine Players Market Share by Revenue

2.8.3 Global Hepatitis A Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Hepatitis A Inactivated Vaccine Market Scenario by Region

3.1 Global Hepatitis A Inactivated Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Hepatitis A Inactivated Vaccine Sales by Region: 2020-2031

3.2.1 Global Hepatitis A Inactivated Vaccine Sales by Region: 2020-2025

3.2.2 Global Hepatitis A Inactivated Vaccine Sales by Region: 2026-2031

3.3 Global Hepatitis A Inactivated Vaccine Revenue by Region: 2020-2031

3.3.1 Global Hepatitis A Inactivated Vaccine Revenue by Region: 2020-2025

3.3.2 Global Hepatitis A Inactivated Vaccine Revenue by Region: 2026-2031

3.4 North America Hepatitis A Inactivated Vaccine Market Facts & Figures by Country

3.4.1 North America Hepatitis A Inactivated Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Hepatitis A Inactivated Vaccine Sales by Country (2020-2031)

3.4.3 North America Hepatitis A Inactivated Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Hepatitis A Inactivated Vaccine Market Facts & Figures by Country

3.5.1 Europe Hepatitis A Inactivated Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Hepatitis A Inactivated Vaccine Sales by Country (2020-2031)

3.5.3 Europe Hepatitis A Inactivated Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Hepatitis A Inactivated Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Hepatitis A Inactivated Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Hepatitis A Inactivated Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Hepatitis A Inactivated Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Hepatitis A Inactivated Vaccine Market Facts & Figures by Country

3.7.1 Latin America Hepatitis A Inactivated Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Hepatitis A Inactivated Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Hepatitis A Inactivated Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Hepatitis A Inactivated Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Hepatitis A Inactivated Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Hepatitis A Inactivated Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Hepatitis A Inactivated Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Hepatitis A Inactivated Vaccine Sales by Type (2020-2031)

4.1.1 Global Hepatitis A Inactivated Vaccine Sales by Type (2020-2025)

4.1.2 Global Hepatitis A Inactivated Vaccine Sales by Type (2026-2031)

4.1.3 Global Hepatitis A Inactivated Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Hepatitis A Inactivated Vaccine Revenue by Type (2020-2031)

4.2.1 Global Hepatitis A Inactivated Vaccine Revenue by Type (2020-2025)

4.2.2 Global Hepatitis A Inactivated Vaccine Revenue by Type (2026-2031)

4.2.3 Global Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Hepatitis A Inactivated Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Hepatitis A Inactivated Vaccine Sales by Application (2020-2031)

5.1.1 Global Hepatitis A Inactivated Vaccine Sales by Application (2020-2025)

5.1.2 Global Hepatitis A Inactivated Vaccine Sales by Application (2026-2031)

5.1.3 Global Hepatitis A Inactivated Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Hepatitis A Inactivated Vaccine Revenue by Application (2020-2031)

5.2.1 Global Hepatitis A Inactivated Vaccine Revenue by Application (2020-2025)

5.2.2 Global Hepatitis A Inactivated Vaccine Revenue by Application (2026-2031)

5.2.3 Global Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Hepatitis A Inactivated Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Hepatitis A Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Hepatitis A Inactivated Vaccine Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Merck

6.2.1 Merck Company Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Hepatitis A Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Merck Hepatitis A Inactivated Vaccine Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Company Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Hepatitis A Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sanofi Hepatitis A Inactivated Vaccine Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Company Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Hepatitis A Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 GlaxoSmithKline Hepatitis A Inactivated Vaccine Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 Health Pharma

6.5.1 Health Pharma Company Information

6.5.2 Health Pharma Description and Business Overview

6.5.3 Health Pharma Hepatitis A Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Health Pharma Hepatitis A Inactivated Vaccine Product Portfolio

6.5.5 Health Pharma Recent Developments/Updates

6.6 Huakang Pharmaceutical

6.6.1 Huakang Pharmaceutical Company Information

6.6.2 Huakang Pharmaceutical Description and Business Overview

6.6.3 Huakang Pharmaceutical Hepatitis A Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Huakang Pharmaceutical Hepatitis A Inactivated Vaccine Product Portfolio

6.6.5 Huakang Pharmaceutical Recent Developments/Updates

6.7 Limin Pharmaceutical

6.7.1 Limin Pharmaceutical Company Information

6.7.2 Limin Pharmaceutical Description and Business Overview

6.7.3 Limin Pharmaceutical Hepatitis A Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Limin Pharmaceutical Hepatitis A Inactivated Vaccine Product Portfolio

6.7.5 Limin Pharmaceutical Recent Developments/Updates

6.8 Xianghe Pharmaceutical

6.8.1 Xianghe Pharmaceutical Company Information

6.8.2 Xianghe Pharmaceutical Description and Business Overview

6.8.3 Xianghe Pharmaceutical Hepatitis A Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Xianghe Pharmaceutical Hepatitis A Inactivated Vaccine Product Portfolio

6.8.5 Xianghe Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Hepatitis A Inactivated Vaccine Industry Chain Analysis

7.2 Hepatitis A Inactivated Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Hepatitis A Inactivated Vaccine Production Mode & Process Analysis

7.4 Hepatitis A Inactivated Vaccine Sales and Marketing

7.4.1 Hepatitis A Inactivated Vaccine Sales Channels

7.4.2 Hepatitis A Inactivated Vaccine Distributors

7.5 Hepatitis A Inactivated Vaccine Customer Analysis

8 Hepatitis A Inactivated Vaccine Market Dynamics

8.1 Hepatitis A Inactivated Vaccine Industry Trends

8.2 Hepatitis A Inactivated Vaccine Market Drivers

8.3 Hepatitis A Inactivated Vaccine Market Challenges

8.4 Hepatitis A Inactivated Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Health Pharma

Huakang Pharmaceutical

Limin Pharmaceutical

Xianghe Pharmaceutical

Pfizer Inc

Sanofi

Merck

List of Tables

Table 1. Global Hepatitis A Inactivated Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Hepatitis A Inactivated Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Hepatitis A Inactivated Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Hepatitis A Inactivated Vaccine Sales (L) of Key Manufacturers (2020-2025)

Table 5. Global Hepatitis A Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Hepatitis A Inactivated Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Hepatitis A Inactivated Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Hepatitis A Inactivated Vaccine Average Price (US$/L) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Hepatitis A Inactivated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Hepatitis A Inactivated Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Hepatitis A Inactivated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Inactivated Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Hepatitis A Inactivated Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Hepatitis A Inactivated Vaccine Sales by Region (2020-2025) & (L)

Table 18. Global Hepatitis A Inactivated Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Hepatitis A Inactivated Vaccine Sales by Region (2026-2031) & (L)

Table 20. Global Hepatitis A Inactivated Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Hepatitis A Inactivated Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Hepatitis A Inactivated Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Hepatitis A Inactivated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Hepatitis A Inactivated Vaccine Sales by Country (2020-2025) & (L)

Table 27. North America Hepatitis A Inactivated Vaccine Sales by Country (2026-2031) & (L)

Table 28. North America Hepatitis A Inactivated Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Hepatitis A Inactivated Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Hepatitis A Inactivated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Hepatitis A Inactivated Vaccine Sales by Country (2020-2025) & (L)

Table 32. Europe Hepatitis A Inactivated Vaccine Sales by Country (2026-2031) & (L)

Table 33. Europe Hepatitis A Inactivated Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Hepatitis A Inactivated Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Hepatitis A Inactivated Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Hepatitis A Inactivated Vaccine Sales by Region (2020-2025) & (L)

Table 37. Asia Pacific Hepatitis A Inactivated Vaccine Sales by Region (2026-2031) & (L)

Table 38. Asia Pacific Hepatitis A Inactivated Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Hepatitis A Inactivated Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Hepatitis A Inactivated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Hepatitis A Inactivated Vaccine Sales by Country (2020-2025) & (L)

Table 42. Latin America Hepatitis A Inactivated Vaccine Sales by Country (2026-2031) & (L)

Table 43. Latin America Hepatitis A Inactivated Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Hepatitis A Inactivated Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Hepatitis A Inactivated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Hepatitis A Inactivated Vaccine Sales by Country (2020-2025) & (L)

Table 47. Middle East and Africa Hepatitis A Inactivated Vaccine Sales by Country (2026-2031) & (L)

Table 48. Middle East and Africa Hepatitis A Inactivated Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Hepatitis A Inactivated Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Hepatitis A Inactivated Vaccine Sales (L) by Type (2020-2025)

Table 51. Global Hepatitis A Inactivated Vaccine Sales (L) by Type (2026-2031)

Table 52. Global Hepatitis A Inactivated Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Hepatitis A Inactivated Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Hepatitis A Inactivated Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Hepatitis A Inactivated Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Hepatitis A Inactivated Vaccine Price (US$/L) by Type (2020-2025)

Table 59. Global Hepatitis A Inactivated Vaccine Price (US$/L) by Type (2026-2031)

Table 60. Global Hepatitis A Inactivated Vaccine Sales (L) by Application (2020-2025)

Table 61. Global Hepatitis A Inactivated Vaccine Sales (L) by Application (2026-2031)

Table 62. Global Hepatitis A Inactivated Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Hepatitis A Inactivated Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Hepatitis A Inactivated Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Hepatitis A Inactivated Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Hepatitis A Inactivated Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Hepatitis A Inactivated Vaccine Price (US$/L) by Application (2020-2025)

Table 69. Global Hepatitis A Inactivated Vaccine Price (US$/L) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 73. Pfizer Hepatitis A Inactivated Vaccine Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 78. Merck Hepatitis A Inactivated Vaccine Product

Table 79. Merck Recent Developments/Updates

Table 80. Sanofi Company Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 83. Sanofi Hepatitis A Inactivated Vaccine Product

Table 84. Sanofi Recent Developments/Updates

Table 85. GlaxoSmithKline Company Information

Table 86. GlaxoSmithKline Description and Business Overview

Table 87. GlaxoSmithKline Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 88. GlaxoSmithKline Hepatitis A Inactivated Vaccine Product

Table 89. GlaxoSmithKline Recent Developments/Updates

Table 90. Health Pharma Company Information

Table 91. Health Pharma Description and Business Overview

Table 92. Health Pharma Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 93. Health Pharma Hepatitis A Inactivated Vaccine Product

Table 94. Health Pharma Recent Developments/Updates

Table 95. Huakang Pharmaceutical Company Information

Table 96. Huakang Pharmaceutical Description and Business Overview

Table 97. Huakang Pharmaceutical Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 98. Huakang Pharmaceutical Hepatitis A Inactivated Vaccine Product

Table 99. Huakang Pharmaceutical Recent Developments/Updates

Table 100. Limin Pharmaceutical Company Information

Table 101. Limin Pharmaceutical Description and Business Overview

Table 102. Limin Pharmaceutical Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 103. Limin Pharmaceutical Hepatitis A Inactivated Vaccine Product

Table 104. Limin Pharmaceutical Recent Developments/Updates

Table 105. Xianghe Pharmaceutical Company Information

Table 106. Xianghe Pharmaceutical Description and Business Overview

Table 107. Xianghe Pharmaceutical Hepatitis A Inactivated Vaccine Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 108. Xianghe Pharmaceutical Hepatitis A Inactivated Vaccine Product

Table 109. Xianghe Pharmaceutical Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Hepatitis A Inactivated Vaccine Distributors List

Table 113. Hepatitis A Inactivated Vaccine Customers List

Table 114. Hepatitis A Inactivated Vaccine Market Trends

Table 115. Hepatitis A Inactivated Vaccine Market Drivers

Table 116. Hepatitis A Inactivated Vaccine Market Challenges

Table 117. Hepatitis A Inactivated Vaccine Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Hepatitis A Inactivated Vaccine

Figure 2. Global Hepatitis A Inactivated Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Hepatitis A Inactivated Vaccine Market Share by Type: 2024 & 2031

Figure 4. 25U/0.5ml Product Picture

Figure 5. 50U/1.0ml Product Picture

Figure 6. Global Hepatitis A Inactivated Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Hepatitis A Inactivated Vaccine Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Hepatitis A Inactivated Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Hepatitis A Inactivated Vaccine Market Size (2020-2031) & (US$ Million)

Figure 13. Global Hepatitis A Inactivated Vaccine Sales (2020-2031) & (L)

Figure 14. Global Hepatitis A Inactivated Vaccine Average Price (US$/L) & (2020-2031)

Figure 15. Hepatitis A Inactivated Vaccine Report Years Considered

Figure 16. Hepatitis A Inactivated Vaccine Sales Share by Manufacturers in 2024

Figure 17. Global Hepatitis A Inactivated Vaccine Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Hepatitis A Inactivated Vaccine Players: Market Share by Revenue in Hepatitis A Inactivated Vaccine in 2024

Figure 19. Hepatitis A Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Hepatitis A Inactivated Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Hepatitis A Inactivated Vaccine Sales Market Share by Country (2020-2031)

Figure 22. North America Hepatitis A Inactivated Vaccine Revenue Market Share by Country (2020-2031)

Figure 23. United States Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Hepatitis A Inactivated Vaccine Sales Market Share by Country (2020-2031)

Figure 26. Europe Hepatitis A Inactivated Vaccine Revenue Market Share by Country (2020-2031)

Figure 27. Germany Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Hepatitis A Inactivated Vaccine Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Hepatitis A Inactivated Vaccine Revenue Market Share by Region (2020-2031)

Figure 34. China Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Hepatitis A Inactivated Vaccine Sales Market Share by Country (2020-2031)

Figure 42. Latin America Hepatitis A Inactivated Vaccine Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Hepatitis A Inactivated Vaccine Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Hepatitis A Inactivated Vaccine Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Hepatitis A Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Hepatitis A Inactivated Vaccine by Type (2020-2031)

Figure 53. Global Revenue Market Share of Hepatitis A Inactivated Vaccine by Type (2020-2031)

Figure 54. Global Hepatitis A Inactivated Vaccine Price (US$/L) by Type (2020-2031)

Figure 55. Global Sales Market Share of Hepatitis A Inactivated Vaccine by Application (2020-2031)

Figure 56. Global Revenue Market Share of Hepatitis A Inactivated Vaccine by Application (2020-2031)

Figure 57. Global Hepatitis A Inactivated Vaccine Price (US$/L) by Application (2020-2031)

Figure 58. Hepatitis A Inactivated Vaccine Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions